Filter
181
Filtered Results: 181
Text search:
DTG
Featured
Recommendations
16
New Publications
65
Language
Document type
No document type
117
Guidelines
31
Studies & Reports
19
Manuals
4
Fact sheets
3
Infographics
2
Strategic & Response Plan
2
Training Material
1
Brochures
1
Situation Updates
1
Countries / Regions
Kenya
7
Zambia
6
South Africa
5
Germany
4
Russia
4
Namibia
4
Mozambique
3
Congo, Democratic Republic of
3
Botswana
3
Myanmar / Burma
3
Nepal
2
Ukraine
2
Lesotho
2
Nigeria
2
Zimbabwe
2
Philippines
2
Global
2
Africa
2
Western and Central Europe
2
Argentina
2
Brazil
2
Ethiopia
2
Tajikistan
1
Ghana
1
Sierra Leone
1
Rwanda
1
Syria
1
Albania
1
Senegal
1
Malawi
1
Guinea
1
Armenia
1
Haiti
1
Cambodia
1
Asia
1
Venezuela
1
Latin America and the Carribbean
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Bangladesh
1
Uganda
1
Eastern Europe
1
Moldova
1
Yemen
1
Central African Republic
1
Chad
1
South Sudan
1
Indonesia
1
Liberia
1
India
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Statistics
29
Policies & Guidelines HIV & TB
24
HIV & STI
15
Guidelines
4
Women & Child Health
4
Drugs & Medical Equipment
3
Capacity Building
3
TB
3
Hepatitis
2
COVID-19
2
Studies & Reports
2
Humanitarian Crisis
2
Reproductive Health
2
Pharmacy & Technologies
2
Zika
1
Paediatrics
1
Emergency Health Kits
1
Buruli Ulcer
1
Humanitarian Aid
1
Annual Report MEDBOX
1
x MEDBOX Issue Brief & Annual Reports x
1
MPOX - Monkeypox
1
Public Health
1
Pediatrics
1
Countries
1
Chagas
1
Policies
1
General Guidelines
1
Maternal Health
1
Neurology & Psychology
1
Disease Prevention & Control
1
Toolboxes
Antiretroviral Treatment ART
25
Clinical Aspects, Treatment & Prevention
18
ART Drug Resistance
14
Treatment Guidelines HIV
12
Treatment & Prevention
11
Children & Adolescents
11
Clinical Aspects
6
Drug resistance
6
Travel Advice
5
Co-Morbidities (except TB)
5
Reports & Studies
5
For General Public
4
General Reports
3
Context & Facts
3
Universal Health Coverage UHC and 90-90-90 Strategy
3
HIV and COVID-19
3
Essential Medicines
3
Access to treatment and laboratory
3
Prevention of mother-to-child transmission (PMTCT)
3
HIV and coinfection
3
TB/HIV Coinfection
3
HIV service delivery
3
Reports & Studies Children HIV
3
Eastern Europe and central Asia
3
Childhood TB
2
HIV testing & services
2
Opportunistic Infections
2
Policies
2
Global
2
Health & Refugee
2
Laboratory
2
Country specific documents
2
COVID-19
2
Essential Medicines & Devices Lists
2
Rational use of Medicine
2
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2
General Aspects
2
HIV / AIDS
2
Lobby and Advocacy
2
Vaccination
2
Behaviour Change/Life Skill Education
1
HIV support organizations
1
Posttraumatic stress disorder Adults
1
Ebola Prevention & Control
1
Vaccination
1
Adults
1
Ukraine
1
Pediatrics
1
Prevention Guidelines
1
Schizophrenia
1
Children
1
Social Worker
1
HIV
1
Ebola
1
Children
1
Microcephaly
1
International
1
General
1
Infection Control General
1
COVID-19
1
For Pregnant Women
1
Training, others
1
Global Impact: Socio-economic, health services, TB & HIV
1
Guidelines
1
Gender Aspects
1
TB/COVID-19
1
Brazil
1
Mental Disorders
1
Situation Reports & Updates
1
General
1
MPOX - Monkeypox
1
Chagas
1
Clinical Aspects & Diagnostics
1
Overview, Studies & Reports
1
Detection & Diagnosis
1
Asia and Pacific
1
Drug resistant TB
1
Policies and guidelines
1
General
1
Neurological Disorders
1
Substance Use Disorders & Addiction
1
Bipolar Affective Disorders
1
Protection
1
Assessment & Response
1
Mental Health
1
Tuberculosis
1
Assessment & Response
1
Roadmaps, Action Plans & Policies
1
Testing Guidelines
1
Travel Medicine
1
Public Health Administration
1
Epidemiology
1
Refugees & Migrants
1
HIV in Key Populations
1
Eastern Europe & Central Asia
1
Depression
1
Kenya
1
Pregnant women
1
Volunteers
1
Preparedness & Prevention
1
MSF Essential Drugs - Practical Guidelines 2022
recommended
Practical guide intended for physicians, pharmacists, nurses and medical auxiliaries. This guide is not a dictionary of pharmacological agents. It is a practical manual intended for health professionals, physicians, pharmacists, nurses and health auxiliaries invoved in curative care and drug managem...
Accessed: 19.10.2019
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs programmes: Central African Republic, Democratic Republic ...
Краткое содержание лекций семинара. На семинаре обсуждались ключевые проблемы в регионе, связанные с заболеваемостью ВИЧ, туберкулезом и гепатитом у людей, употре...
aktualisiert am 14.03.2016
Leitlinie der Deutschen Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG) in Zusammenarbeit mit der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG) und der Deutschen Dermatologischen Gesellschaft
Das Dokument soll dem Erkennen, Bewerten und Bewältigen des Auftretens von Ebolafieber in Deutschland dienen und richtet sich dabei primär an den öffentlichen Gesundheitsdienst sowie medizinisches Fachpersonal in der klinischen, ambulanten und rettungsdienstlichen Versorgung in Deutschland. Es is...
The document is intended to facilitate the detection, evaluation and management of incident EVD cases in Germany. It primarily addresses public health service staff and health care workers in hospitals, outpatient clinics and emergency services in Germany. It is a work in progress, intended to evolv...
Médecins sans Frontières access campaign
Issue Brief
Accessed: 28.11.2019
Hinweise zur Therapie von Affenpocken
recommended
Therapiehinweise des STAKOB unter Mitwirkung von BfArM, DGI, DGPI, DTG, PEI und Pocken Konsiliarlabor RKI - ZBS 1
Em meados de 2021, os programas nacionais de SIDA começaram a fazer a transição do tratamento para crianças que vivem com VIH dolutegravir (DTG) 10 mg sulcado, comprimidos dispersíveis, também conhecido como DTG pediátrico (pDTG). A rápida introdução e implementação do pDTG é uma priori...
This technical report summarizes the discussions on the status of programmatic transition to tenofovir, lamivudine and dolutegravir (TLD) in low– and middle- income countries, addressing the best practices and major challenges faced by HIV programmes.
The latest data on safety and efficacy of do...
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec
le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les
populations sous TAR. Bien que la résistance au DT...
